These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 15265404
1. [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line]. Liu SJ, Xu KX, Wang XF, Hou SK, Wang YC. Zhonghua Wai Ke Za Zhi; 2004 May 22; 42(10):604-6. PubMed ID: 15265404 [Abstract] [Full Text] [Related]
2. Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines. Xu K, Wang X, Ling M, Wong Y. Chin Med J (Engl); 2003 Nov 22; 116(11):1673-7. PubMed ID: 14642133 [Abstract] [Full Text] [Related]
3. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Kyprianou N, Benning CM. Cancer Res; 2000 Aug 15; 60(16):4550-5. PubMed ID: 10969806 [Abstract] [Full Text] [Related]
5. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2. Keledjian K, Kyprianou N. J Urol; 2003 Mar 15; 169(3):1150-6. PubMed ID: 12576871 [Abstract] [Full Text] [Related]
8. Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin. Keledjian K, Borkowski A, Kim G, Isaacs JT, Jacobs SC, Kyprianou N. Prostate; 2001 Jul 01; 48(2):71-8. PubMed ID: 11433417 [Abstract] [Full Text] [Related]
9. Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line. Chang KL, Cheng HL, Huang LW, Hsieh BS, Hu YC, Chih TT, Shyu HW, Su SJ. Cancer Lett; 2009 Apr 08; 276(1):14-20. PubMed ID: 19091461 [Abstract] [Full Text] [Related]
15. Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance. Alberti C. Eur Rev Med Pharmacol Sci; 2007 Apr 08; 11(1):59-64. PubMed ID: 17405349 [Abstract] [Full Text] [Related]
16. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells. Gravina GL, Festuccia C, Millimaggi D, Dolo V, Tombolini V, de Vito M, Vicentini C, Bologna M. Prostate; 2008 May 15; 68(7):793-801. PubMed ID: 18324645 [Abstract] [Full Text] [Related]
17. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved? Siddiqui EJ, Shabbir M, Thompson CS, Mumtaz FH, Mikhailidis DP. Anticancer Res; 2005 May 15; 25(6B):4281-6. PubMed ID: 16309229 [Abstract] [Full Text] [Related]
18. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro]. Deng G, Yu JH, Ye ZQ, Hu ZQ. Zhonghua Nan Ke Xue; 2008 Feb 15; 14(2):116-21. PubMed ID: 18390174 [Abstract] [Full Text] [Related]
19. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. Hsiao CJ, Li TK, Chan YL, Hsin LW, Liao CH, Lee CH, Lyu PC, Guh JH. Biochem Pharmacol; 2008 Feb 15; 75(4):847-56. PubMed ID: 18035333 [Abstract] [Full Text] [Related]
20. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Yun JM, Kweon MH, Kwon H, Hwang JK, Mukhtar H. Carcinogenesis; 2006 Jul 15; 27(7):1454-64. PubMed ID: 16497706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]